Schott Pharma AG & CO KGaA Return on Equity (ROE) Growth & History (1SXP)

Schott Pharma AG & CO KGaA's return on equity was 17.51% for fiscal 2025.

View full Schott Pharma AG & CO KGaA company overview

Schott Pharma AG & CO KGaA annual return on equity history

Schott Pharma AG & CO KGaA annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-09-3017.51%−2.84 pp
20242024-09-3020.36%−1.38 pp
20232023-09-3021.74%−0.63 pp
20222022-09-3022.37%−5.26 pp
20212021-09-3027.62%

Schott Pharma AG & CO KGaA return on equity trends

Between the periods ended 2021-09-30 and 2025-09-30, Schott Pharma AG & CO KGaA's return on equity decreased from 27.62% to 17.51%, a change of −10.11 percentage points. The latest reported quarter, Q3 2026, shows 4.01%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Schott Pharma AG & CO KGaA source filings ↗

Community posts

It’s quiet here.

No posts about 1SXP yet. Start the conversation.

Write the first post